Pandemic coordination externality

Infectious-disease control combines two market failures at scale. Each infection imposes a negative externality on others (the standard SIR externality), so individually-rational behaviour underproduces precaution. And disease surveillance, testing infrastructure, contact-tracing registries, vaccine procurement, and stockpiles are coordination problems with strong network returns and fixed costs — private actors cannot internalise the payoff of having the infrastructure ready before the next pandemic. The combination means pandemic preparedness and response are canonical conditions where state-organised mechanisms outperform decentralised private responses.

confidence: medium highConditions favoring interventionentry added 2026-04-29pandemic_coordination_externality

Institutional features that make the model work

›Standing public health infrastructure

Disease surveillance networks, reference laboratories, contact- tracing capacity maintained continuously between outbreaks. Korea CDC, Taiwan CDC, Vietnam's district health system, Singapore's pandemic-preparedness architecture.

›Rapid testing and tracing scale up

State capacity to commission and deploy mass testing within weeks, plus digital or manual contact-tracing that scales. Korea's 2020 drive-through testing and QR-code tracing; Taiwan's integration of insurance and immigration databases.

›Advance procurement and stockpiles

PPE, antivirals, vaccine reservation contracts, ventilators held against tail-risk pandemic scenarios. Failure mode: UK and US stockpile drawdowns through the 2010s that proved expensive in 2020.

›Vaccine r and d push and pull

Operation Warp Speed (US) and EU/UK advance purchase agreements shifted vaccine supply forward by months via de-risking of manufacturing capacity investment. Pure private incentive would have produced later and smaller supply.

›Clear legal authority and trust

Emergency powers with sunset clauses, transparent communication, and baseline social trust determine compliance. Successful responses combined state capacity with high legitimacy.

Supporting cases

south_korea_2020_mers_to_covid

Korea's 2015 MERS experience triggered reforms to KCDC, testing capacity, and tracing law. In 2020 Korea executed mass testing, digital tracing, and targeted containment without national lockdown, achieving low excess mortality and minimal economic contraction in H1 2020.

taiwan_2020_integrated_response

Taiwan's Central Epidemic Command Center integrated health insurance, immigration, and customs databases from day one. Near-zero community transmission through 2020 despite proximity to mainland China. Institutional infrastructure built after SARS 2003 paid off.

operation_warp_speed_vaccine_acceleration

US federal advance-purchase plus manufacturing-at-risk funding compressed the vaccine timeline by an estimated 6-12 months. A purely private-incentive pathway would have waited for efficacy read-outs before scaling manufacturing, costing lives.

Disconfirming cases

us_decentralised_2020_response

US 2020 response was decentralised across 50 states plus federal-level policy confusion, with fragmented testing, no national tracing, late stockpile response. Excess mortality per capita far above East Asian peers through 2020-21 despite comparable wealth.

uk_2020_early_response_and_stockpile_drawdown

UK pandemic stockpile had been drawn down through the 2010s; PPE procurement collapsed into emergency contracting in March-May 2020. Lockdown substituted for testing and tracing capacity not built in advance.

china_zero_covid_endgame

China's high-capacity early response became a trap when authorities could not exit zero-COVID without a vaccination campaign using mRNA vaccines they had not procured. Illustrates that state capacity without adaptive off-ramp planning is not sufficient.

What this condition is NOT

An endorsement of indefinite lockdowns or of any specific policy adopted under emergency powers
A claim that every state-led pandemic response outperforms every decentralised response
A claim that emergency powers should be unbounded or non-transparent
A general argument for state control of the healthcare delivery system
A claim that 2020-2021 specific policy choices were all correct — many were not

Policy implications

Build and maintain standing public-health infrastructure between pandemics, when the political incentive is weakest. Advance- purchase agreements and at-risk manufacturing investment shift vaccine and therapeutic supply forward. Transparent communication and sunset-clauses on emergency powers maintain legitimacy for the next episode. Private-market incentives will under-provide all of these; state coordination is not a luxury but a minimum condition for effective pandemic response.

Framework position

Pandemic preparedness and response is a textbook case of combined externality and coordination failure. The market equilibrium systematically under-invests in surveillance, stockpiles, vaccine R&D scale-up, and testing-and-tracing infrastructure because the returns accrue in tail scenarios that private actors cannot bank on. The framework endorses sustained public-health infrastructure, advance purchase and manufacturing-at-risk financing for vaccines and therapeutics, and transparent emergency authority with sunset clauses. Empirical variation across the 2020 pandemic tracks institutional preparation (Korea, Taiwan, Vietnam) vs capacity erosion (US, UK early 2020) cleanly. The framework distinguishes between the case for state capacity (strong) and the case for any particular emergency policy choice (case-by-case), and rejects collapsing the two.